Science and Technology · Fixed Dose Combination (FDC) Drugs
What is the primary therapeutic risk associated with a pharmacodynamic mismatch between active components in Fixed Dose Combinations (FDCs)?
Verified Solution4 OptionsUpdated: October 2026👁️1 View
Share:
- 1Inability to package the formulation into standard doses
- 2Increased rate of renal excretion of the active ingredients
- 3Decreased chemical stability of the capsule shell
- 4Reduced therapeutic efficacy or enhanced chemical toxicity✓
Correct answer
Reduced therapeutic efficacy or enhanced chemical toxicity
Download Single Question PDF
Save this question and verified answer as a clean study sheet with live clickable link.
👥
Share with Friends & Study Groups
Challenge your peer aspirants on WhatsApp or Telegram to solve this question!
Online Test Series
Start Free Mock Test →Preparing for Science and Technology?
Practice full-length mock tests with real exam timers, instant score analysis, and all-India ranking.
Chapter Practice
Practice Fixed Dose Combination (FDC) Drugs MCQs →Want more practice questions on Fixed Dose Combination (FDC) Drugs?
Solve complete topic-wise tests with detailed solutions on GkGet.
Related Practice Questions
Recommended practice questions in Science and Technology · Fixed Dose Combination (FDC) Drugs